Key result
Sildenafil and other phosphodiesterase-5 inhibitors demonstrate cardioprotective effects and show potential for future development across several cardiovascular indications.
Design
Review
Authors
Loading...
Supports expanded research on PDE-5 inhibitors across cardiovascular indications; leaves open clinical adoption pending randomized trials.
Sildenafil and other PDE-5 inhibitors show potential for future development in treating various cardiovascular conditions, including hypertension, myocardial infarction, and heart failure.
Rakesh C. Kukreja (2007) conducted a review in Cardiovascular indications. Sildenafil and other PDE-5 inhibitors was evaluated. Sildenafil and other phosphodiesterase-5 inhibitors demonstrate cardioprotective effects and show potential for future development across several cardiovascular indications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: